PRIMARY STUDY

Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction

Key Findings:  Resulting data revealed that β-caryophyllene (at 100 mg/kg) protects against neuro-inflammatory dementia.

Type of Study:  Animal Study

Study Result:  Positive

Study Location(s):  India

Year of Pub:  2021


Cannabinoids Studied: 

Phytocannabinoid Source:  Not Applicable

Terpenes Studied:  ß-Caryophyllene